Concentrix (CNXC)
NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-09-14
$29.27+3.65%
Close 2026-09-14 · 1-day change
NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-09-14
Research Workspace
Put CNXC beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Industrials is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Achieve EPS of $11.48 to $12.07 in FY 2026: Q1 EPS 2.32 vs target 2.57.
View ThesisRevenue growth is slowing — up about 4% over the past year and decelerating.
View GrowthMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 2% on a typical day and fell roughly 63% in its worst 12-month stretch.
View RiskCNXC must improve its earnings to justify its current valuation. The company reported earnings of $2.32, falling short of the target range of $11.48 to $12.07 for FY 2026. It trades at 2.6× P/E, significantly below the peer median of 24×. This suggests that the market may not fully reflect the potential for recovery. The primary risk is the fragile quality of earnings, as reported profits lack strong cash backing. Peer multiples imply a price about 12% below where it trades. This read is provisional.
Trailing returns as of 2026-09-14. CNXC is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 4 analysts currently covering CNXC (as of Sep 2026).
Based on 3 Wall Street analysts offering 12-month price targets for CNXC in the last 4 months.
Continue this research
Compare CNXC with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CNXC Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across our valuation methods, at three horizons. As of 2026-09-14. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No fair value published
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
This applies to all three horizons. The trailing multiples, peer comparison, and quality and trajectory reads on this page are unaffected. Names move in and out of this state day to day as the methods converge or diverge. Method agreement on this name is low.
Bottom 25% on quality vs scored peers
A price-focused, side-by-side fair-value read versus Data Processing & Outsourced Services — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put CNXC next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Significant share price decline indicates market concerns.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-14. EPS is implied from price ÷ P/E. Not investment advice.
Current $29.27
The last 12 months of price, then the range of analyst 12-month targets from today’s $29.27.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Achieve $10.035B to $10.180B revenue in FY 2026
Trimming 2026 outlook impacts revenue growth expectations.
Threatens: Achieve $10.035B to $10.180B revenue in FY 2026
Sales in line but stock drop indicates market concerns.
Earnings transcript likely provides key insights on revenue and EPS.